Blood vessels and parkinsonism

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 277-282

  Barcia, Carlos ^a   Emborg, Marina E ^b   Hirsch, Etienne C ^c   Herrero, María Trinidad ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b RUSH MEDICAL COLLEGE   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Blood Vessels; Glia; Inflammation; Iron; MPTP; Parkinson's disease; Review

Indexed keywords

CYTOKINE; NEUROTOXIN; IRON;

ARTICLE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BLOOD VESSEL; CELL PROLIFERATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; GLIA CELL; HUMAN; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PROBABILITY; DEGENERATIVE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

PRIMATES;

BLOOD VESSELS; HUMANS; IRON; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PARKINSONIAN DISORDERS;

EID: 2142643563     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1145     Document Type: Article

References (54)

1. Hirsch, E.C., Graybiel, A.M., Agid, Y.A.: Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-348. (1988)
2. Agid, Y.: Parkinson's disease: pathophysiology. Lancet 337:1321-1324. (1991)
3. Forno, L.S.: Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-72. (1996)
4. Herrero, M.T., Hirsch, E.C., Kastner, A., Ruberg, M., Luquin, M.R., Laguna, J., Javoy-Agid, F., Obeso, J.A. & Agid, Y.: Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 56:499-511. (1993)
5. Herrero, M.T., Hirsch, E.C., Kastner, A., Luquin, M.R., Javoy-Agid, F., Gonzalo, L.M., Obeso, J.A. & Agid, Y.: Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem. Dev Neurosci 15:37-48. (1993)
6. Krause, D., Faustmann, P.M., Dermietzel, R.: Molecular anatomy of the blood-brain barrier in development and aging. In: Neuroglia in the aging brain. De Vellis JS (ed) Humana Press Inc. Totowa NJ. Pp 291-303. (2002)
7. Reese, T.S. & Karnovsky, M.J.: Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34:207-217. (1967)
8. Rascher, G., Wolburg, H.: The blood-brain barrier in the aging brain. In: Neuroglia in the aging brain. De Vellis JS (ed) Humana Press Inc. Totowa NJ. Pp 305-320. (2002)
9. Götz, M.E., Kunig, G., Riederer, P. & Youdim, M.B.: Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63:37-122. (1994)
10. Hirsch, E.C., Mouatt, A., Thomasset, M., Javoy-Agid, F., Agid, Y. & Graybiel, A.M.: Expression of calbindin D28k-like immunoreactivity in catecholaminergic cell group in the human midbrain. Normal distribution and distribution in Parkinson's disease. Neurodegeneration 1:83-93. (1992)
11. Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P. & Marsden, C.D.: Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52:381-389. (1989)
12. Sofic, E., Paulus, W., Jellinger, K., Riederer, P. & Youdim, M. B. H.: Distribution of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978-982. (1981)
13. Fahn, S. & Cohen, G.: The oxidant stress hypothesis in Parkinson's disease. Evidence supporting it. Ann Neurol 32:804-812. (1992)
14. Marttila, R.J., Lorentz, H. & Rinne, U.K.: Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86(2-3):321-331. (1988)
15. Lange, K.W., Youdim, M.B.H. & Riederer, P.: Neurotoxicity and neuroprotection in Parkinson's disease. J Neural Transm 38:27-44. (1992)
16. Marttila, R.J., Lorentz, H. & Rinne, U.K.: Oxygen toxicity protecting enzymes in Parkinson's disease. J Neuro Sci 86:321-333. (1988)
17. Horovitz, C.T. & Bondy, S.C.: The effect of ions on free radical formation in lung and brain of rats. J Trace Elem Electrolytes J Health Dis 8:167-171. (1994)
18. Dexter, D.T., Carayon, A., Javoy-Agid, F., Agid, Y., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P. & Marsden, C.D.: Alterations on the level of iron, ferritine and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953-1975. (1991)
19. Good, P.P., Olanow, C.W. & Perl, D.P.: Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 593:343-6. (1992)
20. Hirsch, E.C., Brandel, J.P., Galle, P., Javoy-Agid, F. & Agid, Y.: Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease. An X-ray microanalysis. J Neurochem 56:446-451. (1991)
21. Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben-Shachar, D. & Youdim, M.B.: Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J Neurochem 59:1168-1171. (1992)
22. Bomford, A.B. & Munro, H.N.: Transferrin and its receptors: their roles in cell function. Hepatology 5:870-875. (1985)
23. Rowland, L.P., Fink, M.E. & Rubin, L.L: Cerebrospinal fluid: blood-brain barrier, brain oedema and hydrocephalus. In Principles of Neural Science, ed. E.R. Kandel, J.H. Schuartz, T. Jessel, pp. 1050-60. New York: Elsevier. (1992)
24. McLay, R.N., Kimura, M., Banks, W.A. & Kastin, A.J.: Granulocyte-macrophage colony-stimulating factor crosses the blood-brain and blood-spinal cord barriers. Brain 120:2083-2091. (1997)
25. Pardridge, W.M.: Drug delivery to the brain. J Cereb Blood Flow Metab 17:713-731. (1997)
26. Faucheux, B.A., Nillesse, N., Damier, P., Spik, G., Mouatt-Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J.J., Agid, Y. & Hirsch, E.C.: Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 92:9603-9607. (1995)
27. Adams, J.D. Jr, Kalivas, P.W., & Miller C.A.: The acute histopathology of MPTP in the mouse CNS. Brain Res Bull 23:1-17. (1989)
28. Miletich, R.S., Bankiewicz, K.S., Quarantelli, M., Plunkett, R.J., Frank, J., Kopin, I.J. & Di Chiro, G.: MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys. Ann Neurol 35(6):689-697. (1994)
29. Kurkowska-Jastrzebska, I., Wronska, A., Kohutnicka, M., Czlonkowski, A. & Czlonkowska A.: The inflammatory reaction following 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine intoxication in mouse. Exp Neurol 156:50-61. (1999)
30. Risau, W.: Mechanisms of angiogenesis. Nature 386:671-674. (1997)
31. Kerbel, R.S.: Tumor angiogenesis: past, present and the near future. Carcinogenesis 21:505-515. (2000)
32. Carmeliet, P.: Biomedicine. Clotting factors build blood vessels. Science 293:1602-1604. (2001)
33. Carmeliet, P.: Developmental biology. Controlling the cellular brakes. Nature 14;401:657-658. (1999)
34. Carmerliet, P. & Rakesh, K.J.: Angiogenesis in cancer and other diseases. Nature 401:249-251. (2000)
35. Faucheux, B.A., Bonnet, A.M., Agid, Y. & Hirsch, E.C.: Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353:981-982. (1999)
36. Saez Cassanelli, J.L., Barcia, C., García Martínez, V., Navarro-Ruiz, J.M. & Herrero M.T.: Increase of blood vessels in substantia nigra pars compacta in acute MPTP-treated mice. Relation with neuronal loss. Fens Forum (Abstract) p476. (2002)
37. Barcia, C., Sánchez-Bahillo, A., Bautista-Hernández, V., Navarro-Ruiz, J., Fernández-Villalba E., Faucheux, B., Hirsch, E.C. & Herrero, M.T.: Blood Vessels and Neurodegeneration in Parkinson's Disease. Study in Chronic MPTP-treated Monkeys. In: Nicholson & Faull (eds), The Basal Ganglia VII, Kluwer Academic/Plenium Publishers, New York 52:341-347. (2002)
38. Felten, D.L. & Crutcher, K.A.: Neuronal-vascular relationships in the raphe nuclei, locus coeruleus, and substantia nigra in primates. Am J Anat 155:467-481. (1979)
39. Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y. & Hirsch, E.C.: Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172: 151-154 (1994)
40. Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K. & Nagatsu, T.: Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165:208-210 (1994)
41. Hu, W.H., Johnson, H. & Shu, H.B.: Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways. J Biol Chem 274: 30603-30610 (1999)
42. Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H. & Nagatsu,T.: Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm 107: 335-341 (2000)
43. Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debre, P., Agid, Y., Dugas, B. & Hirsch, E.C.: FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 19: 3440-3447 (1999)
44. Adamson, G.M. & Billings, R.E.: Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes. Toxicol Appl Pharmacol 119: 100-107 (1993)
45. Floyd, R.A., Hensley, K., Jaffery, F., Maidt, L., Robinson, K., Pye, Q. & Stewart, C.: Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps. Life Sci 65: 1893-1899 (1999)
46. Forno, L.S., DeLanney, L.E., Irwin, I., Di Monte, D. & Langston, J.W.: Astrocytes and Parkinson's disease. Prog Brain Res 94:429-436. (1992)
47. Parri, R. & Crunelli V.: An astrocyte bridge from synapse to blood flow. Nat Neurosci 6: 5-6. (2003)
48. Zonta, M., Angulo, M.C., Gobbo, S., Rosengarten, B., Hossmann, K.A., Pozzan, T. & Carmignoto, G.: Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6: 43-50. (2003)
49. Abbott, N.J. & Pichon, Y.: The glial blood-brain barrier of crustacea and cephalopods: a review. J Physiol (Paris) 82:304-313. (1987)
50. Stewart, P.A. & Wiley, M.J.: Structural and histochemical features of the avian blood-brain barrier. J Comp Neurol 202:157-167. (1981)
51. Roncalli, L.: Astrocytes and barrier-provided microvasculature in the developing Brain. In: Neuroglia in the aging brain. De Vellis JS (ed) Humana Press Inc. Totowa NJ. Pp 321-335. (2002)
52. Janzer, R.C. & Raff, M.C.: Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325:253-257. (1987)
53. Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T. & Keshet, E.: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738-4747. (1995)
54. Sobel, R.A., Mitchell, M.E. & Fondren, G.: Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 136:1309-1316. (1990)